Related Experiment Video
Updated: May 11, 2026

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
Published on: January 10, 2015
Non-cigarette tobacco and the lung
Michael Schivo1, Mark V Avdalovic, Susan Murin
1Department of Internal Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, University of California, Davis, School of Medicine, 4150 V Street, No. 3400, Sacramento, CA, 95817, USA.
Non-cigarette tobacco products like cigars and waterpipes may be as harmful as cigarettes. Public perception of reduced harm and targeted marketing drive their increasing use, especially among youth.
Area of Science:
- Public Health
- Tobacco Control
- Respiratory Medicine
Background:
- Cigarette smoking causes significant health issues.
- Non-cigarette tobacco products (NCTPs) usage is rising, with potential underestimation of risks.
- Factors like perceived harm reduction and marketing contribute to NCTP popularity.
Purpose of the Study:
- To examine the health impacts of commonly used NCTPs.
- To discuss controversies surrounding the use of NCTPs.
- To compare the risks of NCTPs to traditional cigarette smoking.
Main Methods:
- Review of current literature on NCTP usage and health effects.
- Analysis of factors influencing consumer perception and behavior.
- Discussion of scientific evidence regarding lung health impacts.
Main Results:
- Cigar and waterpipe smoking likely pose similar health risks to cigarette smoking.
- Smokeless tobacco and electronic cigarettes may offer some harm reduction, but risks are not fully understood.
- Misperceptions of lower risk are prevalent, particularly among younger users.
Conclusions:
- The health risks associated with NCTPs, including cigars and waterpipes, are often underestimated.
- Further research is needed to clarify the long-term health consequences of emerging tobacco products.
- Public health strategies must address the rising use and misperceptions surrounding NCTPs.
Related Concept Videos
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Other Pulmonary Disorders
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Chronic Obstructive Pulmonary Disease II: Emphysema
Gross Anatomy of the Lungs

